cyclosporine has been researched along with Fasting Hypoglycemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, A; Bi, YA; Kazierad, DJ; Litchfield, J; Mathialagan, S; Pfefferkorn, JA; Varma, MVS | 1 |
| Eesa, M; Scott, JN; Sharma, P | 1 |
| Alkharfy, KM | 1 |
| Korsgren, O; Tufveson, G; von Zur-Mühlen, B | 1 |
| Bahr, BA; Blomgren, K; Chan, PH; Ferrand-Drake, M; Gidö, G; Hansen, AJ; Karlsson, JO; Kroemer, G; Wieloch, T; Zamzami, N; Zhu, C | 1 |
| Bengtsson, F; Ferrand-Drake, M; Friberg, H; Halestrap, AP; Wieloch, T | 1 |
| Ferrand-Drake, M; Friberg, H; Wieloch, T | 1 |
1 review(s) available for cyclosporine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Toxic and acquired metabolic encephalopathies: MRI appearance.
Topics: Brain Diseases, Metabolic; Carbon Monoxide Poisoning; Cocaine; Cyclosporine; Diagnosis, Differential; Ethylene Glycol; Hepatic Encephalopathy; Humans; Hypoglycemia; Magnetic Resonance Imaging; Methanol; Metronidazole; Myelinolysis, Central Pontine | 2009 |
6 other study(ies) available for cyclosporine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Effect of Hepatic Organic Anion-Transporting Polypeptide 1B Inhibition and Chronic Kidney Disease on the Pharmacokinetics of a Liver-Targeted Glucokinase Activator: A Model-Based Evaluation.
Topics: Area Under Curve; Biological Transport; Cyclosporine; Drug Interactions; Enzyme Inhibitors; Glucokinase; HEK293 Cells; Humans; Hypoglycemia; Imidazoles; Kidney; Liver; Liver-Specific Organic Anion Transporter 1; Membrane Transport Proteins; Nicotinic Acids; Renal Insufficiency, Chronic; Tissue Distribution | 2019 |
Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model.
Topics: Alloxan; Animals; Area Under Curve; Blood Glucose; Cholesterol; Cyclosporine; Diabetes Mellitus, Experimental; Dogs; Hypoglycemia; Immunosuppressive Agents; Kinetics; Lipoproteins, LDL; Models, Statistical; Streptozocin | 2009 |
Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Hypoglycemia; Immune Tolerance; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Middle Aged; Tacrolimus | 2012 |
Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia.
Topics: Animals; Apoptosis Inducing Factor; Calcium; Calpain; Caspase 3; Caspases; Cell Count; Cyclosporine; Cytochrome c Group; Dentate Gyrus; Enzyme Activation; Flavoproteins; Hypoglycemia; Intracellular Fluid; Male; Membrane Proteins; Microelectrodes; Neurons; Protein Transport; Rats; Rats, Wistar; Tacrolimus | 2003 |
Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death.
Topics: Animals; Cell Death; Cell Respiration; Cyclosporine; Drug Evaluation, Preclinical; Hippocampus; Hypoglycemia; Immunosuppressive Agents; Male; Mitochondria; Mitochondrial Swelling; Neurons; Permeability; Rats; Rats, Wistar; Tacrolimus | 1998 |
Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia.
Topics: Animals; Coma; Cyclosporine; DNA Fragmentation; Electrophoresis, Agar Gel; Hippocampus; Hypoglycemia; In Situ Nick-End Labeling; Male; Mitochondria; Permeability; Rats; Rats, Wistar; Tacrolimus | 1999 |